Literature DB >> 1281478

Tumor necrosis factor stimulates multiple serine/threonine protein kinases in Swiss 3T3 and L929 cells. Implication of casein kinase-2 and extracellular signal-regulated kinases in the tumor necrosis factor signal transduction pathway.

J Van Lint1, P Agostinis, V Vandevoorde, G Haegeman, W Fiers, W Merlevede, J R Vandenheede.   

Abstract

Incubation of Swiss 3T3 or L929 cells with tumor necrosis factor (TNF) leads to the rapid stimulation of several cytosolic Ser/Thr kinases active toward myelin basic protein, the S6 peptide (RRLSSLR), the G peptide (SPQPSRRGSESSEE), and Kemptide (LRRASLG). This confirms the hypothesis that kinases other than protein kinases A and C may be involved in the TNF signal transduction. Chromatography on Mono Q resolved multiple kinase peaks with each substrate tested and moreover revealed a TNF-mediated casein kinase-2 activation in both cell lines, measurable with the specific RRREEESEEE peptide or with the G peptide. The TNF-stimulated myelin basic protein kinases-1 and -2 were identified as extracellular signal-regulated kinases-2 and -1, respectively, based on their elution pattern on Mono Q chromatography, their inactivation by protein phosphatase action, their reaction with phosphothreonine and phosphotyrosine antibodies, and by their migration on sodium dodecyl sulfate-polyacrylamide gel electrophoresis as 42- and 44-kDa proteins recognized by anti-extracellular signal-regulated kinase antibodies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281478

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

Review 1.  TNF ligands and receptors--a matter of life and death.

Authors:  David J MacEwan
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

2.  sNASP inhibits TLR signaling to regulate immune response in sepsis.

Authors:  Feng-Ming Yang; Yong Zuo; Wei Zhou; Chuan Xia; Bumsuk Hahm; Mark Sullivan; Jinke Cheng; Hui-Ming Chang; Edward Th Yeh
Journal:  J Clin Invest       Date:  2018-05-07       Impact factor: 14.808

Review 3.  Protein kinase CK2, an important regulator of the inflammatory response?

Authors:  Nishi N Singh; Dipak P Ramji
Journal:  J Mol Med (Berl)       Date:  2008-04-25       Impact factor: 4.599

4.  Ras signaling in tumor necrosis factor-induced apoptosis.

Authors:  J C Trent; D J McConkey; S M Loughlin; M T Harbison; A Fernandez; H N Ananthaswamy
Journal:  EMBO J       Date:  1996-09-02       Impact factor: 11.598

Review 5.  Casein kinase II in signal transduction and cell cycle regulation.

Authors:  D W Litchfield; B Lüscher
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

6.  Full activation of a nuclear species of protein phosphatase-1 by phosphorylation with protein kinase A and casein kinase-2.

Authors:  A Van Eynde; M Beullens; W Stalmans; M Bollen
Journal:  Biochem J       Date:  1994-02-01       Impact factor: 3.857

7.  Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IkappaB alpha phosphorylation and degradation.

Authors:  P Schwenger; D Alpert; E Y Skolnik; J Vilcek
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

8.  Sphingolipid metabolites differentially regulate extracellular signal-regulated kinase and stress-activated protein kinase cascades.

Authors:  E Coroneos; Y Wang; J R Panuska; D J Templeton; M Kester
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

9.  Tumor necrosis factor alpha inhibits signaling from the insulin receptor.

Authors:  G S Hotamisligil; D L Murray; L N Choy; B M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

10.  Effects of granulocyte-macrophage colony-stimulating factor and tumour necrosis factor-alpha on tyrosine phosphorylation and activation of mitogen-activated protein kinases in human neutrophils.

Authors:  W H Waterman; R I Sha'afi
Journal:  Biochem J       Date:  1995-04-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.